Literature DB >> 140541

[Investigation of alkylation in rat liver chromatin after application of 3H-cyclophosphamid--"fine-distribution" and kinetics].

E Harbers, P Warnecke, H Hollandt, K Kruse.   

Abstract

The alkylation of chromatin constituents (DNA, histones and non-histones) in liver cell nuclei was investigated at various times after intraperitoneal injection of rats with 3H-cyclophosphamid. The highest alkylation was found in the DNA, the lowest in the histones; the euchromatic portions were alkylated several times higher compared to those of the heterochromatin. The eventual elimination of 3H-activity with time indicates that cyclophosphamid leads to repair processes in the DNA, this conclusion being supported by other experimental observations. In some of the 16 subfractions of the nonhistone proteins, alkylated portions are apparantly eliminated by normal protein turnover; however, in other nonhistones this elimination is inhibited, whereby in one subfraction it seems to be accelerated. The results of analog experiments with 14C-tryptophan as a precursor for nonhistone protein synthesis serve as a reference for this. In supplementary in-vitro model experiments using triaziquon as an alkylating agent indications for DNA-Protein-cross-links in chromatin could be obtained by the technique of X-ray low angle scattering, and according to sedimentation behaviour.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 140541     DOI: 10.1007/bf00305362

Source DB:  PubMed          Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol        ISSN: 0084-5353


  30 in total

1.  Studies on deoxyribonucleoproteins. IX. Subfractions of deoxyribonucleoproteins from rat and mouse liver.

Authors:  E Harbers; H Hollandt; C Eilers-König; R Schneider; C Struttmann; P Warnecke
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1975-06

2.  STUDIES WITH MUSTARDS. V. IN VIVO FIXATION OF C14 OF LABELED ALKYLATING AGENTS BY BILATERALLY GROWN SENSITIVE AND RESISTANT TUMORS.

Authors:  G P WHEELER; J A ALEXANDER
Journal:  Cancer Res       Date:  1964-09       Impact factor: 12.701

3.  [A NEW DEVELOPMENT FOR CONTINUOUS, CARRIER-FREE ELECTROPHORESIS. ON THE SEPARATION OF HIGH-MOLECULAR WEIGHT AND THICKLY DISPERSED PARTICLES].

Authors:  K HANNIG
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1964

4.  Observations on the in vivo alkylation of Ehrlich tumor cell DNA by nitrogen mustards.

Authors:  R J RUTMAN; W J STEELE; C C PRICE
Journal:  Biochem Biophys Res Commun       Date:  1961-03-24       Impact factor: 3.575

5.  On the mechanism of action of the alkylating agents. I. Interaction of alkylating agents with nucleic acids.

Authors:  E G TRAMS; M V NADKARNI; P K SMITH
Journal:  Cancer Res       Date:  1961-05       Impact factor: 12.701

6.  [The principles of evaluation of biological and medical trials with radioisotopes].

Authors:  E HARBERS
Journal:  Klin Wochenschr       Date:  1954-05-01

7.  Repair replication and unscheduled DNA synthesis in mammalian cell lines showing differential sensitivity to alkylating agents.

Authors:  M Fox; B W Fox
Journal:  Mutat Res       Date:  1973-07       Impact factor: 2.433

8.  Studies on deoxyribonucleoproteins. 8. Isolation and characterization of nonhistone proteins from euchromatic and heterochromatic deoxyribonucleoprotein of rat liver.

Authors:  P Warnecke; K Kruse; E Harbers
Journal:  Biochim Biophys Acta       Date:  1973-12-07

9.  Cross-linking and repair of DNA in sensitive and resistant strains of E. coli treated with nitrogen mustard.

Authors:  K W Kohn; N H Steigbigel; C L Spears
Journal:  Proc Natl Acad Sci U S A       Date:  1965-05       Impact factor: 11.205

10.  Repair replication, unscheduled DNA synthesis, and the repair of mammalian DNA.

Authors:  R B Painter; J E Cleaver
Journal:  Radiat Res       Date:  1969-03       Impact factor: 2.841

View more
  1 in total

Review 1.  [The role of enzymatic DNA repair in carcinogenesis and cancer chemotherapy].

Authors:  E Harbers
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1978-08-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.